Abi-Saab Walid (CIK 1985973) reported 13 SEC Form 4 insider transactions across 1 companies over the past 18 months (most recent 2026-07-02). Recent activity: Buy QURE (10,000 shares), Sell QURE (10,000 shares), Sell QURE (20,000 shares), Sell QURE (1,434 shares), Buy QURE (25,000 shares). Source: SEC Form 4.
| Date | Company | Role | Type | Shares | Value |
|---|---|---|---|---|---|
| 2026-07-02 | uniQure N.V. (QURE) | Chief Medical Officer | Buy | 10,000 | $55,900 |
| 2026-07-02 | uniQure N.V. (QURE) | Chief Medical Officer | Sell | 10,000 | $464,600 |
| 2026-07-02 | uniQure N.V. (QURE) | Chief Medical Officer | Sell | 20,000 | $928,000 |
| 2026-06-30 | uniQure N.V. (QURE) | Chief Medical Officer | Sell | 1,434 | $67,197 |
| 2026-05-12 | uniQure N.V. (QURE) | Chief Medical Officer | Buy | 25,000 | $139,750 |
| 2026-05-12 | uniQure N.V. (QURE) | Chief Medical Officer | Sell | 25,000 | $627,500 |
| 2026-05-12 | uniQure N.V. (QURE) | Chief Medical Officer | Sell | 20,000 | $500,000 |
| 2026-03-06 | uniQure N.V. (QURE) | Chief Medical Officer | Buy | 41,700 | $0 |
| 2026-03-06 | uniQure N.V. (QURE) | Chief Medical Officer | Sell | 808 | $7,320 |
| 2026-03-04 | uniQure N.V. (QURE) | Chief Medical Officer | Sell | 1,660 | $16,517 |
| 2025-07-01 | uniQure N.V. (QURE) | Chief Medical Officer | Sell | 1,466 | $20,407 |
| 2025-03-05 | uniQure N.V. (QURE) | Chief Medical Officer | Buy | 38,000 | $0 |
| 2025-03-05 | uniQure N.V. (QURE) | Chief Medical Officer | Sell | 1,350 | $13,891 |
Source: SEC Form 4 filings · as of 2026-07-02